Dover Total Cost of Revenue decreased by 1.8% to $1.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $1.12B to $1.26B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a -0.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26B | $1.26B | $1.27B | $1.31B | $1.38B | $1.39B | $867.54M | $1.33B | $1.34B | $1.22B | $924.63M | $1.19B | $1.20B | $1.22B | $1.18B | $1.12B | $1.23B | $1.24B | $1.28B | $1.26B |
| QoQ Change | — | +0.3% | +0.3% | +3.2% | +5.3% | +0.6% | -37.4% | +53.5% | +0.7% | -9.1% | -24.2% | +28.3% | +0.8% | +2.0% | -3.0% | -5.4% | +9.9% | +1.0% | +2.7% | -1.8% |
| YoY Change | — | — | — | — | +9.4% | +9.6% | -31.6% | +1.8% | -2.6% | -12.0% | +6.6% | -10.9% | -10.8% | +0.1% | +28.1% | -5.6% | +2.9% | +2.0% | +7.9% | +12.0% |